(Q27094895)
Statements
C1C(=C(NC(S1)C(C(=O)OCC(C(=O)[O-])N)NC(=O)CC2=CC=CS2)C(=O)[O-])C=CC3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-]
1 reference
Nitrocefin Acyl-Serine (English)
4 October 2016
C1C(=C(N[C@@H](S1)[C@@H](C(=O)OC[C@H](C(=O)[O-])N)NC(=O)CC2=CC=CS2)C(=O)[O-])/C=C/C3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-]
1 reference
Nitrocefin Acyl-Serine (English)
4 October 2016
Identifiers
1 reference
Nitrocefin Acyl-Serine (English)
4 October 2016
1 reference
Nitrocefin Acyl-Serine (English)
4 October 2016
1 reference
2-{2-(2-Amino-2-carboxyethoxy)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5-[2-(2,4-dinitrophenyl)vinyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid (English)
4 October 2016
1 reference
2-{2-(2-Amino-2-carboxylatoethoxy)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5-[2-(2,4-dinitrophenyl)vinyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylate (English)
4 October 2016
1 reference
Nitrocefin Acyl-Serine (English)
4 October 2016
1 reference
Nitrocefin Acyl-Serine (English)
4 October 2016